| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | CA2536015C Modified oligonucleotides for telomerase inhibition |
| 12/10/2013 | CA2453173C Mycobacterial antigens expressed during latency |
| 12/10/2013 | CA2451026C Mycobacterial antigens expressed under low oxygen tension |
| 12/10/2013 | CA2443617C Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 12/10/2013 | CA2385032C G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2013 | CA2341349C Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| 12/05/2013 | WO2013181666A2 Antisense compounds targeting genes associated with fibronectin |
| 12/05/2013 | WO2013181613A1 Mirna for the diagnosis and treatment of autoimmune and inflammatory disease |
| 12/05/2013 | WO2013181471A2 Matrix metalloproteinase cleavable protein polymers for cancer gene therapy |
| 12/05/2013 | WO2013181454A1 Plant lectins as carriers of associated drug substances into animal and human cells |
| 12/05/2013 | WO2013181440A1 Supercoiled minivectors as a tool for dna repair, alteration and replacement |
| 12/05/2013 | WO2013181326A1 Generation of functional and durable endothelial cells from human amniotic fluid-derived cells |
| 12/05/2013 | WO2013181228A1 Dna modifying fusion proteins and methods of use thereof |
| 12/05/2013 | WO2013180038A1 Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
| 12/05/2013 | WO2013179669A1 Carrier for gene introduction use, gene introduction agent, methods for producing said carrier and said gene introduction agent, and method for introducing gene into cell |
| 12/05/2013 | WO2013178635A1 Cytochrome p450 suicide gene system |
| 12/05/2013 | WO2013177922A1 Polypeptide for treating alzheimer's disease and genetic vaccine |
| 12/05/2013 | US20130324592 Lipid Nanoparticles for Treating Ocular Diseases |
| 12/05/2013 | US20130324586 Inhibition of Hairless Protein mRNA |
| 12/05/2013 | US20130323313 Mucus Penetrating Gene Carriers |
| 12/05/2013 | US20130323302 Treatment of amd using aav sflt-1 |
| 12/05/2013 | US20130323278 Chimeric Flavivirus Vaccines |
| 12/05/2013 | US20130323254 Therapeutic anti-tirc7 antibodies for use in immune related and other diseases |
| 12/05/2013 | US20130323205 Oncolytic adenoviral vectors and methods and uses related thereto |
| 12/05/2013 | CA2876860A1 Supercoiled minivectors as a tool for dna repair, alteration and replacement |
| 12/04/2013 | EP2669378A1 Cytochrome P450 suicide gene system |
| 12/04/2013 | EP2669377A2 Modified iRNA agents |
| 12/04/2013 | EP2669297A1 Humanized anti-egfr antibody l4-h3 and coding gene thereof |
| 12/04/2013 | CN1701121B Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 12/04/2013 | CN103429742A Composition and method for treating endocrine, gastrointestinal or autoimmune disorder |
| 12/04/2013 | CN103429270A Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
| 12/04/2013 | CN103429254A Fragment of secreted heat shock protein-90alpha (Hsp90alpha) as vaccines or epitope for monoclonal antibody drugs or target for small molecule drugs against a range of solid human tumors |
| 12/04/2013 | CN103421887A Applications of CIT gene and relevant medicines |
| 12/04/2013 | CN103421886A Applications of CIZI gene and relevant medicines |
| 12/04/2013 | CN103421884A Applications of human FZR1 gene and related medicines of the human FZR1 gene |
| 12/04/2013 | CN103421846A Applications of diamino carbamate cross-linked polyethyleneimine in gene therapy |
| 12/04/2013 | CN103421843A Coded H5N1 subtype avian influenza virus synonymous hemagglutinin (HA) protein, gene of synonymous neuraminidase (NA) protein and application of HA and NA |
| 12/04/2013 | CN103421817A Synthetic mMEP of PRRSV (Porcine Reproductive and Respiratory Syndrome Virus) and application thereof |
| 12/04/2013 | CN103421800A Recombinant gene, recombinant carrier and recombinant cell for treating spinal cord injuries |
| 12/04/2013 | CN103421796A siRNA (short interfering RNA) for reducing human OPN gene expression and related medicine thereof |
| 12/04/2013 | CN103421792A Method for inhibiting tumor cell growth by silencing eIF4H (Eukaryotic translation initiation factor 4H) and application of method |
| 12/04/2013 | CN103421791A SiRNA of inhibiting expression of TLR2 of human cytomegalovirus and application thereof |
| 12/04/2013 | CN103421738A Pharmacy applications of MTA1 and inhibitor thereof |
| 12/04/2013 | CN103421117A Immune-enhanced virus-like particles, expression vector thereof, and preparation and application thereof |
| 12/04/2013 | CN103421093A ZMIZ1-mediated targeting knockout transcription activator-like effector nuclease, preparation method and applications |
| 12/04/2013 | CN103417991A Application of human miR-148a to preparation of medicine for improving adipose cell insulin sensitivity |
| 12/04/2013 | CN103417990A Application of human miR-148a to preparation of medicine for promoting adipose cell proliferation |
| 12/04/2013 | CN103417989A Application of human miR-26b to preparation of medicine for improving insulin sensitivity |
| 12/04/2013 | CN103417988A Application of CDK2 gene to preparation of leukemia induced differentiation therapeutic drug |
| 12/04/2013 | CN103417987A Application of miR-148 to proliferation of pancreatic beta cells |
| 12/04/2013 | CN103417986A Application of MTDH to preparation or screening of drugs for curing hyperaldosteronism adenomata or adrenal tumors |
| 12/04/2013 | CN103417985A Application of antisense nucleotide sequences of ribosomal protein analogues RPL22L1 in preparing medicines capable of suppressing growth of ovarian cancer cells |
| 12/04/2013 | CN103417984A Nano dual-drug delivery system for targeting brain gliomas and preparation method thereof |
| 12/04/2013 | CN103417983A Novel apoptosis-related molecule TMEM106A and applications thereof |
| 12/04/2013 | CN103417982A Application of human original longevity assurance gene 2 in preparation of drugs for improving sensitivity of breast cancer cells against anticancer drugs |
| 12/04/2013 | CN103417968A Application of poly cytosine binding protein-2 inhibitor to prepare medicaments for treating human glioma |
| 12/04/2013 | CN103417967A Application of inhibitor of CXCL-10 in preparation of drug for treatment and/or prevention of lung injury |
| 12/04/2013 | CN103416312A Plants as functional siRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN103416311A Plants as functional microRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN102698279B Preparation method of amphipathic gama-polyglutanmic acid nanodrug carrier |
| 12/04/2013 | CN102675425B Functional mycobacterium tuberculosis antigen polypeptide and application thereof |
| 12/04/2013 | CN102657874B A hydrogel-encapsulated lentivirus Lingo-1 RNAi complex for repairing nerve injury and a preparation method thereof |
| 12/04/2013 | CN102653554B Functional mycobacterium tuberculosis antigen polypeptide and application thereof |
| 12/04/2013 | CN102352368B ING4 and OSM double-gene co-expression vector and application thereof |
| 12/03/2013 | US8598335 Organic compositions to treat Beta-ENaC-related diseases |
| 12/03/2013 | US8598146 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith |
| 12/03/2013 | US8598140 Aptamers to β-NGF and their use in treating β-NGF mediated diseases and disorders |
| 12/03/2013 | US8598139 Lipid formulated dsRNA targeting the PCSK9 gene |
| 12/03/2013 | US8598133 Methods for treating pain |
| 12/03/2013 | US8597656 Process for the production of immunogenic compositions |
| 12/03/2013 | US8597637 Breast cancer therapy using an engineered respiratory syncytial virus |
| 12/03/2013 | CA2519227C Nogo receptor binding protein |
| 12/03/2013 | CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/03/2013 | CA2397207C Novel stra6 polypeptides |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013177535A2 Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta |
| 11/28/2013 | WO2013177468A2 Methods and compositions for modulating apolipoprotein(a) expression |
| 11/28/2013 | WO2013177275A1 Cranberry xyloglucan oligosaccharide composition |
| 11/28/2013 | WO2013177248A2 Modulation of enhancer rna mediated gene expression |
| 11/28/2013 | WO2013177214A2 Epitope focusing by variable effective antigen surface concentration |
| 11/28/2013 | WO2013177194A1 Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage |
| 11/28/2013 | WO2013177176A1 Compositions and methods for inducing myoblast differentiation and myotube formation |
| 11/28/2013 | WO2013176624A1 Microrna-320, alone or in conjunction with tpa, for treatment of acute ischemic stroke |
| 11/28/2013 | WO2013176503A1 Tau protein mediated neurodegenerative disease therapeutic agent |
| 11/28/2013 | WO2013176477A1 Rna-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor |
| 11/28/2013 | WO2013174409A1 Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings |
| 11/28/2013 | WO2013122375A9 Pharmaceutical composition for viral treatment, and method for screening antiviral agent |
| 11/28/2013 | WO2012125828A8 Methods of treating breast cancer with anthracycline therapy |
| 11/28/2013 | US20130317089 Compositions and Methods Useful for Treatment and Prevention of Incontinence |
| 11/28/2013 | US20130316452 Modalities for the treatment of degenerative diseases of the retina |
| 11/28/2013 | US20130316451 Modalities for the treatment of degenerative diseases of the retina |
| 11/28/2013 | US20130315985 Process for preparing purified nucleic acid and the use thereof |
| 11/28/2013 | US20130315872 Neuron-specific retrograde transport vector |
| 11/28/2013 | DE10144906B4 Verfahren zur großtechnischen Herstellung von Impfstoffen A process for the large scale production of vaccines |
| 11/27/2013 | EP2666858A1 Modified iRNA agents |
| 11/27/2013 | EP2666482A1 Particle composition and pharmaceutical composition using particle composition |
| 11/27/2013 | EP2665748A1 Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced) |
| 11/27/2013 | EP2665739A1 Methods and compositions related to synergistic responses to oncogenic mutations |
| 11/27/2013 | EP2665489A1 Combination therapy for cancer |